APA

Wang E., Simard M., Bergeron Y., Beauchamp D. & Bergeron M. G. (20000501). In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. : Antimicrobial agents and chemotherapy.

Chicago

Wang E, Simard M, Bergeron Y, Beauchamp D and Bergeron M G. 20000501. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. : Antimicrobial agents and chemotherapy.

Harvard

Wang E., Simard M., Bergeron Y., Beauchamp D. and Bergeron M. G. (20000501). In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. : Antimicrobial agents and chemotherapy.

MLA

Wang E, Simard M, Bergeron Y, Beauchamp D and Bergeron M G. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. : Antimicrobial agents and chemotherapy. 20000501.